Research Article

Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and Aβ25–35-Induced Rat Model of Alzheimer’s Disease

Figure 11

Effect of OMO on monoamine neurotransmitter levels in the cerebral cortex of D-galactose and Aβ25–35-treated AD rats. The graphs show the levels of (a) NE, (b) E, (c) DA, (d) 5-HT, (e) L-DOPA, (f) DOPAC, (g) 5-HIAA, and (h) HVA. These values are expressed as mean ± SD, n = 8. and , compared with the normal control group; and , compared with the model group.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)